MBOT
Microbot Medical Inc (MBOT)
Healthcare • NASDAQ • $2.130.00%
- Symbol
- MBOT
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Price
- $2.13
- Daily Change
- 0.00%
- Market Cap
- $143.05M
- Trailing P/E
- N/A
- Forward P/E
- -6.26
- 52W High
- $4.67
- 52W Low
- $1.60
- Analyst Target
- $8.50
- Dividend Yield
- N/A
- Beta
- 1.06
Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body's vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomou…
Company websiteResearch MBOT on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.